Drug Side Effects
Search
IMPLANT SITE HYPERTROPHY
IMPLANT SITE HYPERTROPHY
was reported 9 times
IMPLANT SITE HYPERTROPHY is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Polyene Antifungal [EPC]
1
0.0000
1
Progestin [EPC]
3
0.0000
2
Calcineurin Inhibitor Immunosuppressant [EPC]
1
0.0000
3
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000